Asthma - use lowest effective dose. Consider step down at each review. Consider switch if appropriate
Alternative to Seretide Evohaler / Seretide 250 Accuhaler
Note: when switching patients already using Beclometasone 250mcg CFC inhaler (e.g. Clenil), Fostair 100/6 can be prescribed and dose adjusted according to response
Fluticasone and salmeterol (Pressurised inhalation)
Non Formulary
BRANDS
Airflusal
Aloflute
Avenor
Combisal
Sirdupla- No dose counter although cost effective
Sereflo -Even though cost effective and has dose counter, licensed for >18 yrs and clinicians would rather have patients on formoterol rather than salmeterol
Fluticasone and salmeterol (Inhalation powder)
Non Formulary
BRANDS
Airflusal Forspiro
Fixkoh Airmaster
Fusacomb Easyhaler
Seretide Accuhaler
Stalpex
Fluticasone and salmeterol (Seretide 500 Accuhaler®)
Non Formulary
Fluticasone and salmeterol (Seretide®) (Inhaler)
Non Formulary
Seretide 250 Evohaler- Black from 23rd May 2023.
Ok for historic patients
Should be prescribed by the intended brand to ensure patients are maintained on the formulation they are used to.
Mometasone (Asmanex®)
Non Formulary
Mometasone Furoate (Nasonex Spray®)
Non Formulary
Prescribe generically
Montelukast (Singulair® ) (Oral presentations)
Non Formulary
Use in line with recommendations in BTS-SIGN asthma guideline
Key
Restricted Drug
Unlicensed
Link to adult BNF
Link to children's BNF
Link to SPCs
Cytotoxic Drug
Controlled Drug
High Cost Medicine
Cancer Drugs Fund
NHS England
Homecare
ICB
Low carbon footprint
Medium carbon footprint
High carbon footprint
Status
Description
Medicines which are suitable for initiation and maintenance prescribing by primary and secondary care clinicians. These medicines should be initiated and prescribed within their licensed indications
Amber Specialist Initiation: Initiation and maintenance of prescribing by Specialists and transfer to Primary Care prescribing when appropriate. This may be supported by a RICaD, annotated within the formulary entry.
Amber Shared Care: Initiation and maintenance of prescribing by Specialists and transfer to Primary Care prescribing, in accordance with an ESCA, annotated within the formulary entry.
Amber Specialist Recommendation: Initiation and maintenance of prescribing in Primary Care following recommendation from a specialist.
Medicines for initiation and maintenance prescribing by Specialists (hospital or GPs with Special Interest) only
Positive NICE TA and /or awaiting local clarification on place in therapy; Please contact your Medicines Optimisation team for more information.
Non-formulary Medicines which APC/Trust DTC has actively reviewed and do not recommend for use.
